Found: 2
Select item for more details and to access through your institution.
Pure Red Cell Aplasia and Chromosomal Abnormality in a Patient With Lung Adenocarcinoma Receiving Immune Checkpoint Inhibitors: A Case Report.
- Published in:
- In Vivo, 2024, v. 38, n. 3, p. 1509, doi. 10.21873/invivo.13599
- By:
- Publication type:
- Article
Comparison of the efficacy of first‑/second‑generation EGFR‑tyrosine kinase inhibitors and osimertinib for EGFR‑mutant lung cancer with negative or low PD‑L1 expression.
- Published in:
- Molecular & Clinical Oncology, 2024, v. 20, n. 6, p. N.PAG, doi. 10.3892/mco.2024.2741
- By:
- Publication type:
- Article